Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

Outcomes of the 340B Drug Pricing Program: A Scoping Review

November 22, 2023

JAMA Network

By Ryan Know, Junyi Wang, and William Feldman

Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy

November 3, 2023

JAMA Network

By T. Joseph Mattingly II, David Hyman, and Gei Bai

The 340B Drug Pricing Program: Litigation, Administration, and Reform

September 28, 2023

SSRN

By Ryan Knox and Ameet Sarpatwari

Procompetitive Health Care Reform Options for a Divided Congress

March 16, 2023

USC Schaeffer and Brookings Institution

By Loren Adler and Benedic Ippolito
Scroll to Top